Natalie Holt

ORCID: 0000-0001-5265-3167 · 1 paper in corpus · active 2013

Study types

  • dataset 1
dataset 2013
Faculty of 1000 evaluation for A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induced constipation.
·doi:10.3410/f.718026254.793480322

Read the full review for this Faculty Opinions recommended article: A phase 2, double-blind, randomized, placebo-controlled, dose-escalation study to evaluate the efficacy, safety, and tolerability of naloxegol in patients with opioid-induc…